202833-08-7

202833-08-7 structure
202833-08-7 structure
  • Name: Atorolimumab
  • Chemical Name: Atorolimumab
  • CAS Number: 202833-08-7
  • Molecular Formula:
  • Molecular Weight:
  • Catalog: Signaling Pathways Immunology/Inflammation PD-1/PD-L1
  • Create Date: 2023-01-25 09:55:07
  • Modify Date: 2024-04-06 16:59:10
  • Atorolimumab (P3x22914G4) is a monoclonal antibody used for immunotherapies targeting programmed death-1 (PD-1)[1].

Name Atorolimumab
Description Atorolimumab (P3x22914G4) is a monoclonal antibody used for immunotherapies targeting programmed death-1 (PD-1)[1].
Related Catalog
References

[1]. Oura K, et al. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2022 Dec 14;9:1279-1298.  

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.